Key details
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Enrollment target
~50 participants
Primary completion
January 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated February 2025